Replies to post #201713 on Biotech Values

[DewDiligence]

EYEG -10% on common-and-convertible-preferred financing:

http://finance.yahoo.com/news/eyegate-announces-3-77-million-120000311.html

[DewDiligence]

EYEG +38% on phase-1/2 data in post-operative pain following cataract surgery:

http://finance.yahoo.com/news/eyegate-announces-positive-top-line-123000277.html

The stock fell in June when interim data from this trial were reported (#msg-123024021).